These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38926199)

  • 1. Commentary on "The Effect of Sampling Cannula on In Vitro Dissolution Testing with USP Paddle Method".
    Abend A; Stippler E; Kühl N; Externbrink A; Smith KL; Mann J
    AAPS J; 2024 Jun; 26(4):73. PubMed ID: 38926199
    [No Abstract]   [Full Text] [Related]  

  • 2. The Effect of Sampling Cannula on In Vitro Dissolution Testing with USP Paddle Method.
    Gao Z; Smith A
    AAPS J; 2023 Apr; 25(3):46. PubMed ID: 37101085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution testing of powders for inhalation: influence of particle deposition and modeling of dissolution profiles.
    May S; Jensen B; Weiler C; Wolkenhauer M; Schneider M; Lehr CM
    Pharm Res; 2014 Nov; 31(11):3211-24. PubMed ID: 24852894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of a new device (spindle) for improved characterization of drug release (dissolution) of pharmaceutical products.
    Qureshi SA; Shabnam J
    Eur J Pharm Sci; 2003 Jul; 19(4):291-7. PubMed ID: 12885394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the use of a 200 ml vessel suitable for dissolution of low dose drug products?
    Crail DJ; Tunis A; Dansereau R
    Int J Pharm; 2004 Jan; 269(1):203-9. PubMed ID: 14698592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution testing of sublingual tablets: a novel in vitro method.
    Rachid O; Rawas-Qalaji M; Simons FE; Simons KJ
    AAPS PharmSciTech; 2011 Jun; 12(2):544-52. PubMed ID: 21523516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-Vitro Drug Dissolution Studies in Medicinal Compounds.
    Bozal-Palabiyik B; Uslu B; Ozkan Y; Ozkan SA
    Curr Med Chem; 2018; 25(33):4020-4036. PubMed ID: 29577852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical properties of the USP dissolution test with pooled samples.
    Saccone CD; Meneces NS; Tessore J
    PDA J Pharm Sci Technol; 2005; 59(5):310-9. PubMed ID: 16316066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP dissolution IV: comparison of methods.
    Carstensen JT; Lai TY; Prasad VK
    J Pharm Sci; 1978 Sep; 67(9):1303-7. PubMed ID: 690839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation.
    Salehi N; Al-Gousous J; Hens B; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2024 May; 21(5):2406-2414. PubMed ID: 38639477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation.
    Berben P; Ashworth L; Beato S; Bevernage J; Bruel JL; Butler J; Dressman J; Schäfer K; Hutchins P; Klumpp L; Mann J; Nicolai J; Ojala K; Patel S; Powell S; Rosenblatt K; Tomaszewska I; Williams J; Augustijns P
    Eur J Pharm Biopharm; 2019 Jul; 140():141-148. PubMed ID: 31051249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations.
    Sun DD; Lee PI
    AAPS J; 2015 Nov; 17(6):1317-26. PubMed ID: 26338234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms.
    Brown CK; Friedel HD; Barker AR; Buhse LF; Keitel S; Cecil TL; Kraemer J; Morris JM; Reppas C; Stickelmeyer MP; Yomota C; Shah VP
    AAPS PharmSciTech; 2011 Jun; 12(2):782-94. PubMed ID: 21688063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated sampling of in vitro dissolution medium: effect of sampling probes on dissolution rate of prednisone tablets.
    Savage TS; Wells CE
    J Pharm Sci; 1982 Jun; 71(6):670-3. PubMed ID: 7097531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the effect of solubility and density gradients on local hydrodynamics and drug dissolution in the USP 4 dissolution apparatus.
    D'Arcy DM; Liu B; Corrigan OI
    Int J Pharm; 2011 Oct; 419(1-2):175-85. PubMed ID: 21843609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inferential procedure for the probability of passing the USP dissolution test.
    Chiang C; Chen CF; Huang MY; Liu JP
    Pharm Stat; 2012; 11(1):32-8. PubMed ID: 21506255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of coning phenomena for irregular particles in paddle dissolution test.
    Higuchi M; Nishida S; Yoshihashi Y; Tarada K; Sugano K
    Eur J Pharm Sci; 2015 Aug; 76():213-6. PubMed ID: 25998150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Dissolution Media and Presence of Alcohol on the In Vitro Performance of Pharmaceutical Products Containing an Insoluble Drug.
    Friuli V; Bruni G; Musitelli G; Conte U; Maggi L
    J Pharm Sci; 2018 Jan; 107(1):507-511. PubMed ID: 28624418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems.
    Phillips DJ; Pygall SR; Cooper VB; Mann JC
    J Pharm Pharmacol; 2012 Nov; 64(11):1549-59. PubMed ID: 23058042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemical determination of dissolution rates of lyophilized pharmaceutical formulations.
    Webb SD; Koval CA; Randolph CM; Randolph TW
    Anal Chem; 2001 Nov; 73(21):5296-301. PubMed ID: 11721932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.